Sahni Vikram, Teames Charles, Seifert Rachel, Conley McGuire, deShazo Rosemary, Powell Douglas, Rhoads Jamie L W, Clarke Jennie T, Hansen Christopher B, Zone John J, Hull Christopher M, Hopkins Zachary H
Department of Dermatology, Autoimmune Skin Diseases Clinic, University of Utah Spencer F. Eccles School of Medicine, 30 N Mario Capecchi Drive level 1 South, Salt Lake City, 84132, UT, USA.
Spencer F Eccles School of Medicine, University of Utah, Salt Lake City, 84132, USA.
Arch Dermatol Res. 2025 Jan 9;317(1):207. doi: 10.1007/s00403-024-03681-y.
There is a reported association between oral contact allergy and oral lichen planus (OLP). Likewise oral squamous cell carcinoma (oSCC) is associated with OLP. It is hypothesized that chronic inflammation may contribute to oSCC risk. Ostensibly, we hypothesized that allergy testing positivity may increase inflammation and thus may be associated with oSCC in OLP. As a secondary objective, we assessed oSCC prevalence in OLP, allergen prevalence in OLP, and associations between allergy testing and OLP phenotype. To do this, we performed a retrospective cohort evaluation of OLP patients seen at the University of Utah from 2015 to 2022. Odds of oSCC occurrence by allergy testing status, clinical/demographic factors and asssociations between allergy testing and OLP phenotype were assessed using univariable and multivariable logistic regression. The prevalence of oSCC and allergy testing (patch + scratch testing) results were summarized descriptively. OLP diagnoses were confirmed by our OLP-specialized clinicians, and/or histologic assessment. Allergy testing was performed by two specialized dermatologists. oSCC diagnosis was identified via chart review and histologic data. Among 587 OLP patients identified, 133 were allergy tested and 77.4% were positive (52.4% metals, 55.3% flavorings/fragrances, 47.6% preservatives). Of those with a positive allergy test, 10 (25.6%) developed oSCC compared with 2 (5.1%) of patients with a negative allergy test. There was insufficient evidence to support an association between allergy positivity and oSCC (OR = 1.55, 95% CI 0.76-3.15). A higher percent of symptomatic visits was the only other clinical and/or demographic factor associated with oSCC occurrence (median 87.5% vs. 66.7%, p = 0.03). Of the OLP disease characteristics assessed (mouth area involved, extent of disease involvement, erosive subtype, etc.), only OLP involving the gingiva was associated with positive allergy testing (OR = 2.54,1.11-5.81). These data suggest that allergy test positivity may not be associated with oSCC. However, it was associated with more pervasive symptomatology, suggesting a possible association with more severe or recalcitrant disease.
据报道,口腔接触性过敏与口腔扁平苔藓(OLP)之间存在关联。同样,口腔鳞状细胞癌(oSCC)也与OLP有关。据推测,慢性炎症可能会增加患oSCC的风险。显然,我们推测过敏测试呈阳性可能会加重炎症,因此可能与OLP患者患oSCC有关。作为次要目标,我们评估了OLP患者中oSCC的患病率、OLP患者中的过敏原患病率,以及过敏测试与OLP表型之间的关联。为此,我们对2015年至2022年在犹他大学就诊的OLP患者进行了回顾性队列评估。使用单变量和多变量逻辑回归评估了根据过敏测试状态、临床/人口统计学因素得出的oSCC发生几率,以及过敏测试与OLP表型之间的关联。对oSCC的患病率和过敏测试(斑贴试验+划痕试验)结果进行了描述性总结。OLP诊断由我们的OLP专科临床医生和/或组织学评估确认。过敏测试由两名专科皮肤科医生进行。通过病历审查和组织学数据确定oSCC诊断。在确定的587例OLP患者中,133例进行了过敏测试,77.4%呈阳性(金属过敏占52.4%,香料/香精过敏占55.3%,防腐剂过敏占47.6%)。在过敏测试呈阳性的患者中,10例(25.6%)发生了oSCC,而过敏测试呈阴性的患者中有2例(5.1%)发生了oSCC。没有足够的证据支持过敏阳性与oSCC之间存在关联(比值比=1.55,95%置信区间0.76-3.15)。较高比例的症状性就诊是与oSCC发生相关的唯一其他临床和/或人口统计学因素(中位数87.5%对66.7%,p=0.03)。在评估的OLP疾病特征(受累口腔区域、疾病累及范围、糜烂亚型等)中,只有累及牙龈的OLP与过敏测试呈阳性相关(比值比=2.54,1.11-5.81)。这些数据表明,过敏测试阳性可能与oSCC无关。然而,它与更普遍的症状有关,这表明可能与更严重或更难治疗的疾病有关。